CORRECTION: PTC Therapeutics Q3 Adj. EPS $0.94 Beats $0.34 Estimate, Sales $357.807M Beat $306.399M Estimate

PTC Therapeutics (NASDAQ:PTCT) reported quarterly earnings of $0.94 per share which beat the analyst consensus estimate of $0.34 by 176.47 percent. This is a 370 percent increase over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $357.807 million which beat the analyst consensus estimate of $306.399 million by 16.78 percent. This is a 69.57 percent increase over sales of $211.007 million the same period last year.